Potential of human fetal chorionic stem cells for the treatment of osteogenesis imperfecta

Stem Cells and Development

Volumn 23, Issue 3, 2014, Pages 262-276

  Jones, Gemma N ^a   Moschidou, Dafni ^a   Abdulrazzak, Hassan ^a   Kalirai, Bhalraj Singh ^a   Vanleene, Maximilien ^a   Osatis, Suchaya ^a   Shefelbine, Sandra J ^a   Horwood, Nicole J ^a   Marenzana, Massimo ^a   De Coppi, Paolo ^b   Bassett, J H Duncan ^a   Williams, Graham R ^a   Fisk, Nicholas M ^c   Guillot, Pascale V ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; SMAD3 PROTEIN; TRANSCRIPTION FACTOR RUNX2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE DEVELOPMENT; BONE MASS; BONE RADIOGRAPHY; BONE REMODELING; CARTILAGE CELL; CELL DIFFERENTIATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CORTICAL BONE; ENCHONDRAL OSSIFICATION; EPIPHYSIS; FEMALE; FETAL STEM CELL; FLOW CYTOMETRY; FRACTURE REDUCTION; HUMAN; HUMAN CELL; HUMAN FETAL EARLY CHORIONIC STEM CELL; HYPERTROPHY; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MALE; MICRORADIOGRAPHY; MORPHOMETRICS; NEWBORN; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOGENESIS IMPERFECTA; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SPINE FRACTURE; STEM CELL TRANSPLANTATION; UPREGULATION; WESTERN BLOTTING;

ANIMALS; BONE AND BONES; CELL- AND TISSUE-BASED THERAPY; CHONDROCYTES; CHONDROGENESIS; CHORION; COLLAGEN TYPE I; DISEASE MODELS, ANIMAL; FEMALE; FETAL STEM CELLS; FETUS; FRACTURES, BONE; GENE EXPRESSION; HUMANS; INJECTIONS, INTRAPERITONEAL; MICE; OSTEOBLASTS; OSTEOGENESIS IMPERFECTA; PLACENTA; PREGNANCY; STEM CELL TRANSPLANTATION; TRANSPLANTATION, HETEROLOGOUS;

EID: 84893062494     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2013.0132     Document Type: Article

References (73)

1. Dalgleish R. (1997). The human type I collagen mutation database. Nucleic Acids Res 25:181-187
2. Cohen-Solal L, L. Zylberberg, A. Sangalli, M. Gomez Lira and M Mottes. (1994). Substitution of an aspartic acid for glycine 700 in the alpha 2(I) chain of type I collagen in a recurrent lethal type II osteogenesis imperfecta dramatically affects the mineralization of bone. J Biol Chem 269:14751-14758
3. Stoss H and P Freisinger. (1993). Collagen fibrils of osteoid in osteogenesis imperfecta: Morphometrical analysis of the fibril diameter. Am J Med Genet 45:257
4. Van Dijk FS, G. Pals, RR. Van Rijn, PG. Nikkels and JM Cobben. (2010). Classification of osteogenesis imperfecta revisited. Eur J Med Genet 53:1-5
5. Letocha AD, HL. Cintas, JF. Troendle, JC. Reynolds, CE. Cann,. et al. (2005). Controlled trial of pamidronate in children with types III and IV osteogenesis imperfecta confirms vertebral gains but not short-Term functional improvement. J Bone Miner Res 20:977-986
6. Ward LM, F. Rauch, MP. Whyte, J D'Astous, PE. Gates,. et al. (2011). Alendronate for the treatment of pediatric osteogenesis imperfecta: A randomized placebo-controlled study. J Clin Endocrinol Metab 96:355-364
7. Rauch F and FH Glorieux. (2004). Osteogenesis imperfecta. Lancet 363:1377-1385
8. Horwitz EM, DJ. Prockop, PL. Gordon, WW. Koo, LA. Fitzpatrick,. et al. (2001). Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta. Blood 97:1227-1231
9. Horwitz EM, PL. Gordon, WK. Koo, JC. Marx, MD. Neel,. et al. (2002). Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone. Proc Natl Acad Sci USA 99:8932-8937
10. Le Blanc K, C. Gotherstrom, O. Ringden, M. Hassan, R. McMahon,. et al. (2005). Fetal mesenchymal stem-cell engraftment in bone after in utero transplantation in a patient with severe osteogenesis imperfecta. Transplantation 79:1607-1614
11. Pereira RF, MD O'Hara, AV. Laptev, KW. Halford, MD. Pollard,. et al. (1998). Marrow stromal cells as a source of progenitor cells for nonhematopoietic tissues in transgenic mice with a phenotype of osteogenesis imperfecta. Proc Natl Acad Sci USA 95:1142-1147
12. Panaroni C, R. Gioia, A. Lupi, R. Besio, SA. Goldstein,. et al. (2009). In utero transplantation of adult bone marrow decreases perinatal lethality and rescues the bone phenotype in the knockin murine model for classical, dominant osteogenesis imperfecta. Blood 114:459-468
13. Wang X, F. Li and C Niyibizi. (2006). Progenitors systemically transplanted into neonatal mice localize to areas of active bone formation in vivo: Implications of cell therapy for skeletal diseases. Stem Cells 24:1869-1878
14. Li F, X. Wang and C Niyibizi. (2007). Distribution of singlecell expanded marrow derived progenitors in a developing mouse model of osteogenesis imperfecta following systemic transplantation. Stem Cells 25:3183-3193
15. Guillot PV, O. Abass, JH. Bassett, SJ. Shefelbine, G. Bou-Gharios,. et al. (2008). Intrauterine transplantation of human fetal mesenchymal stem cells from first-Trimester blood repairs bone and reduces fractures in osteogenesis imperfecta mice. Blood 111:1717-1725
16. Vanleene M, Z. Saldanha, KL. Cloyd, G. Jell, G. Bou-Gharios,. et al. (2011). Transplantation of human fetal blood stem cells in the osteogenesis imperfecta mouse leads to improvement in multiscale tissue properties. Blood 117:1053-1060
17. Portmann-Lanz CB, A. Schoeberlein, A. Huber, R. Sager, A. Malek,. et al. (2006). Placental mesenchymal stem cells as potential autologous graft for pre-And perinatal neuroregeneration. Am J Obstet Gynecol 194:664-673
18. Poloni A, V. Rosini, E. Mondini, G. Maurizi, S. Mancini,. et al. (2008). Characterization and expansion of mesenchymal progenitor cells from first-Trimester chorionic villi of human placenta. Cytotherapy 10:690-697
19. Barlow S, G. Brooke, K. Chatterjee, G. Price, R. Pelekanos,. et al. (2008). Comparison of human placenta-And bone marrowderived multipotent mesenchymal stem cells. Stem Cells Dev 17:1095-1107
20. Soncini M, E. Vertua, L. Gibelli, F. Zorzi, M. Denegri,. et al. (2007). Isolation and characterization of mesenchymal cells from human fetal membranes. J Tissue Eng Regen Med 1:296-305
21. Li CD, WY. Zhang, HL. Li, XX. Jiang, Y. Zhang, et al. (2005). Isolation and identification of a multilineage potential mesenchymal cell from human placenta. Placenta [Epub ahead of print]; DOI: 10.1016/j.placenta.2005.08.003
22. Yen BL, HI. Huang, CC. Chien, HY. Jui, BS. Ko,. et al. (2005). Isolation of multipotent cells from human term placenta. Stem Cells 23:3-9
23. Jones GN, D. Moschidou, TI. Puga-Iglesias, K. Kuleszewicz, M. Vanleene, et al. (2012). Ontological differences in first compared to third trimester human fetal placental chorionic stem cells. PLoS One 7:e43395
24. Guillot PV, C. Gotherstrom, J. Chan, H. Kurata, NM. Fisk. (2007). Human first-Trimester fetal MSC express pluripotency markers and grow faster and have longer telomeres than adult MSC. Stem Cells 25:646-654
25. Bassett JH, A. Boyde, PG. Howell, RH. Bassett, TM. Galliford,. et al. (2010). Optimal bone strength and mineralization requires the type 2 iodothyronine deiodinase in osteoblasts. Proc Natl Acad Sci USA 107:7604-7609
26. Chappard D, S. Palle, C. Alexandre, L. Vico and G Riffat. (1987). Bone embedding in pure methyl methacrylate at low temperature preserves enzyme activities. Acta Histochem 81:183-190
27. Yongchang Y and Y Wang. (2013). ATDC5: An excellent in vitro model cell line for skeletal development. J Cell Biochem 114:1223-1229
28. Dominici M, K. Le Blanc, I. Mueller, I. Slaper-Cortenbach, F. Marini,. et al. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315-317
29. Adewumi O, B. Aflatoonian, L. Ahrlund-Richter, M. Amit, PW. Andrews,. et al. (2007). Characterization of human embryonic stem cell lines by the International Stem Cell Initiative. Nat Biotechnol 25:803-816
30. Skottman H, M. Mikkola, K. Lundin, C. Olsson, AM. Stromberg,. et al. (2005). Gene expression signatures of seven individual human embryonic stem cell lines. Stem Cells 23:1343-1356
31. Gotherstrom C, O. Ringden, C. Tammik, E. Zetterberg, M. Westgren,. et al. (2004). Immunologic properties of human fetal mesenchymal stem cells. Am J Obstet Gynecol 190:239-245
32. McKee MD and A Nanci. (1996). Osteopontin: An interfacial extracellular matrix protein in mineralized tissues. Connect Tissue Res 35:197-205
33. Lian JB, GS. Stein, C. Stewart, E. Puchacz, S. Mackowiak,. et al. (1989). Osteocalcin: Characterization and regulated expression of the rat gene. Connect Tissue Res 21:61-68; discussion 69
34. Ryoo HM, HM. Hoffmann, T. Beumer, B. Frenkel, DA. Towler,. et al. (1997). Stage-specific expression of Dlx-5 during osteoblast differentiation: Involvement in regulation of osteocalcin gene expression. Mol Endocrinol 11:1681-1694
35. Chipman SD, HO. Sweet, DJ. McBride, Jr., MT Davisson, SC. Marks, Jr.,. et al. (1993). Defective pro alpha 2(I) collagen synthesis in a recessive mutation in mice: A model of human osteogenesis imperfecta. Proc Natl Acad Sci USA 90:1701-1705
36. James CG, LA. Stanton, H. Agoston, V. Ulici, TM. Underhill, et al. (2010). Genome-wide analyses of gene expression during mouse endochondral ossification. PLoS One 5:e8693
37. Haleem-Smith H, R. Calderon, Y. Song, RS. Tuan and FH Chen. (2012). Cartilage oligomeric matrix protein enhances matrix assembly during chondrogenesis of human mesenchymal stem cells. J Cell Biochem 113:1245-1252
38. Bi W, JM. Deng, Z. Zhang, RR. Behringer and B de Crombrugghe. (1999). Sox9 is required for cartilage formation. Nat Genet 22:85-89
39. Bell DM, KK. Leung, SC. Wheatley, LJ. Ng, S. Zhou,. et al. (1997). SOX9 directly regulates the type-II collagen gene. Nat Genet 16:174-178
40. Lefebvre V, W. Huang, VR. Harley, PN. Goodfellow and B de Crombrugghe. (1997). SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro alpha1(II) collagen gene. Mol Cell Biol 17:2336-2346
41. Tsuji Y, Y. Shimada, T. Takeshita, N. Kajimura, S. Nomura,. et al. (2000). Cryptic dimer interface and domain organization of the extracellular region of metabotropic glutamate receptor subtype 1. J Biol Chem 275:28144-28151
42. Muir H. (1995). The chondrocyte, architect of cartilage. Biomechanics, structure, function and molecular biology of cartilage matrix macromolecules. Bioessays 17:1039-1048
43. Amano K, K. Hata, A. Sugita, Y. Takigawa, K. Ono,. et al. (2009). Sox9 family members negatively regulate maturation and calcification of chondrocytes through up-regulation of parathyroid hormone-related protein. Mol Biol Cell 20:4541-4551
44. Huang W, UI. Chung, HM. Kronenberg and B de Crombrugghe. (2001). The chondrogenic transcription factor Sox9 is a target of signaling by the parathyroid hormone-related peptide in the growth plate of endochondral bones. Proc Natl Acad Sci USA 98:160-165
45. Huang W, X. Zhou, V. Lefebvre and B de Crombrugghe. (2000). Phosphorylation of SOX9 by cyclic AMP-dependent protein kinase A enhances SOX9's ability to transactivate a Col2a1 chondrocyte-specific enhancer. Mol Cell Biol 20: 4149-4158
46. Ferguson CM, EM. Schwarz, PR. Reynolds, JE. Puzas, RN. Rosier,. et al. (2000). Smad2 and 3 mediate transforming growth factor-beta1-induced inhibition of chondrocyte maturation. Endocrinology 141:4728-4735
47. Arias JL, O. Nakamura, MS. Fernandez, JJ. Wu, P. Knigge,. et al. (1997). Role of type X collagen on experimental mineralization of eggshell membranes. Connect Tissue Res 36 :21-33
48. Martin A, S. Liu, V. David, H. Li, A. Karydis,. et al. (2011). Bone proteins PHEX and DMP1 regulate fibroblastic growth factor Fgf23 expression in osteocytes through a common pathway involving FGF receptor (FGFR) signaling. FASEB J 25:2551-2562
49. Lorenz-Depiereux B, M. Bastepe, A. Benet-Pages, M. Amyere, J. Wagenstaller,. et al. (2006). DMP1 mutations in autosomal recessive hypophosphatemia implicate a bone matrix protein in the regulation of phosphate homeostasis. Nat Genet 38:1248-1250
50. Wang X, K. Harimoto, S. Xie, H. Cheng, J. Liu,. et al. (2010). Matrix protein biglycan induces osteoblast differentiation through extracellular signal-regulated kinase and Smad pathways. Biol Pharm Bull 33:1891-1897
51. Christiansen HE, U. Schwarze, SM. Pyott, A. Al Swaid, M. Al Balwi,. et al. (2010). Homozygosity for a missense mutation in SERPINH1, which encodes the collagen chaperone protein HSP47, results in severe recessive osteogenesis imperfecta. Am J Hum Genet 86:389-398
52. Stacey A, J. Bateman, T. Choi, T. Mascara, W. Cole,. et al. (1988). Perinatal lethal osteogenesis imperfecta in transgenic mice bearing an engineered mutant pro-Alpha 1(I) collagen gene. Nature 332:131-136
53. Ducy P, R. Zhang, V. Geoffroy, AL. Ridall and G Karsenty. (1997). Osf2/Cbfa1: A transcriptional activator of osteoblast differentiation. Cell 89:747-754
54. Komori T, H. Yagi, S. Nomura, A. Yamaguchi, K. Sasaki,. et al. (1997). Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89:755-764
55. Otto F, AP. Thornell, T. Crompton, A. Denzel, KC. Gilmour,. et al. (1997). Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is. essential for osteoblast differentiation and bone development. Cell 89:765-771
56. Karsenty G and EF Wagner. (2002). Reaching a genetic and molecular understanding of skeletal development. Dev Cell 2:389-406
57. Kurata H, PV. Guillot, J. Chan and NM Fisk. (2007). Osterix induces osteogenic gene expression but not differentiation in primary human fetal mesenchymal stem cells. Tissue Eng 13:1513-1523
58. Giustina A, G. Mazziotti and E Canalis. (2008). Growth hormone, insulin-like growth factors, and the skeleton. Endocr Rev 29:535-559
59. Mochizuki H, Y. Hakeda, N. Wakatsuki, N. Usui, S. Akashi,. et al. (1992). Insulin-like growth factor-I supports formation and activation of osteoclasts. Endocrinology 131:1075-1080
60. Niu T and CJ Rosen. (2005). The insulin-like growth factor-I gene and osteoporosis: A critical appraisal. Gene 361:38-56
61. Yakar S, CJ. Rosen, WG. Beamer, CL. Ackert-Bicknell, Y. Wu,. et al. (2002). Circulating levels of IGF-1 directly regulate bone growth and density. J Clin Invest 110:771-781
62. Jones GN, D. Moschidou, K. Lay, H. Abdulrazzak, M. Vanleene,. et al. (2012). Upregulating CXCR4 in human fetal mesenchymal stem cells enhances engraftment and bone mechanics in a mouse model of osteogenesis imperfecta. Stem Cells Transl Med 1:70-78
63. Granero-Molto F, JA. Weis, MI. Miga, B. Landis, TJ. Myers,. et al. (2009). Regenerative effects of transplanted mesenchymal stem cells in fracture healing. Stem Cells 27:1887-1898
64. Li H, X. Jiang, J. Delaney, T. Franceschetti, I. Bilic-Curcic,. et al. (2010). Immature osteoblast lineage cells increase osteoclastogenesis in osteogenesis imperfecta murine. Am J Pathol 176:2405-2413
65. Kalajzic I, J. Terzic, Z. Rumboldt, K. Mack, A. Naprta,. et al. (2002). Osteoblastic response to the defective matrix in the osteogenesis imperfecta murine (oim) mouse. Endocrinology 143:1594-1601
66. Zhou Y, W. Fan, I. Prasadam, R. Crawford and Y Xiao. (2012). Implantation of osteogenic differentiated donor mesenchymal stem cells causes recruitment of host cells. J Tissue Eng Regen Med
67. Li X, W. Ling, A. Pennisi, Y. Wang, S. Khan,. et al. (2011). Human placenta-derived adherent cells prevent bone loss, stimulate bone formation, and suppress growth of multiple myeloma in bone. Stem Cells 29:263-273
68. Zheng Q, G. Zhou, R. Morello, Y. Chen, X. Garcia-Rojas,. et al. (2003). Type X collagen gene regulation by Runx2 contributes directly to its hypertrophic chondrocyte-specific expression in vivo. J Cell Biol 162:833-842
69. Otsuru S, PL. Gordon, K. Shimono, R. Jethva, R. Marino,. et al. (2012). Transplanted bone marrow mononuclear cells and MSCs impart clinical benefit to children with osteogenesis imperfecta through different mechanisms. Blood 120:1933-1941
70. Zebaze RM, AC. Jones, MG. Pandy, MA. Knackstedt and E Seeman. (2011). Differences in the degree of bone tissue mineralization account for little of the differences in tissue elastic properties. Bone 48:1246-1251
71. Gupta HS, S. Schratter, W. Tesch, P. Roschger, A. Berzlanovich,. et al. (2005). Two different correlations between nanoindentation modulus and mineral content in the bonecartilage interface. J Struct Biol 149:138-148
72. Vanleene M, A. Porter, PV. Guillot, A. Boyde, M. Oyen,. et al. (2012). Ultra-structural defects cause low bone matrix stiffness despite high mineralization in osteogenesis imperfecta mice. Bone 50:1317-1323
73. Frayssinet P, JL. Jouve and E Viehweger. (2004). Cartilage cells. In: Biomechanics and Biomaterials in Orthopaedics. Thorngren KG, DG. Poitout, R. Kotz, eds. Springer, London, pp 219